Does IMDEVIMAB Cause Covid-19 pneumonia? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Covid-19 pneumonia have been filed in association with IMDEVIMAB. This represents 9.7% of all adverse event reports for IMDEVIMAB.
42
Reports of Covid-19 pneumonia with IMDEVIMAB
9.7%
of all IMDEVIMAB reports
3
Deaths
40
Hospitalizations
How Dangerous Is Covid-19 pneumonia From IMDEVIMAB?
Of the 42 reports, 3 (7.1%) resulted in death, 40 (95.2%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Covid-19 pneumonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMDEVIMAB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does IMDEVIMAB Cause?
Infusion related reaction (94)
Dyspnoea (84)
Nausea (48)
Hypoxia (40)
Pyrexia (39)
Oxygen saturation decreased (34)
Vomiting (32)
Dizziness (31)
Cough (27)
Flushing (27)
What Other Drugs Cause Covid-19 pneumonia?
RITUXIMAB (1,489)
DEXAMETHASONE (758)
LENALIDOMIDE (750)
PREDNISONE (749)
OCRELIZUMAB (669)
TACROLIMUS (622)
MYCOPHENOLATE MOFETIL (594)
PREDNISOLONE (479)
METHOTREXATE (472)
CYCLOPHOSPHAMIDE (430)
Which IMDEVIMAB Alternatives Have Lower Covid-19 pneumonia Risk?
IMDEVIMAB vs IMEGLIMIN
IMDEVIMAB vs IMETELSTAT
IMDEVIMAB vs IMIDAPRIL
IMDEVIMAB vs IMIGLUCERASE
IMDEVIMAB vs IMIPENEM